Nature reporters discuss Dolly Parton's advocacy for vaccines and public health alongside promising phase III results for a personalised mRNA cancer vaccine for melanoma.
We use essential cookies to run the site. Optional analytics and public-page session replay help us improve World Wide. Learn more.